Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,109,611
-
Share change
-
+603,430
-
Total reported value
-
$342,872,903
-
Put/Call ratio
-
0%
-
Price per share
-
$8.35
-
Number of holders
-
121
-
Value change
-
+$7,903,036
-
Number of buys
-
52
-
Number of sells
-
48
Institutional Holders of JOUNCE THERAPEUTICS INC - COM (JNCE) as of Q4 2021
As of 31 Dec 2021 JOUNCE THERAPEUTICS INC - COM (JNCE) had 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 41,109,611 shares of stock of the company.
Largest 10 holders included Deep Track Capital, LP, PFM Health Sciences, LP, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, TRV GP II, LLC, BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, Sofinnova Investments, Inc., and Woodline Partners LP.
This table shows 121 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.